NextGen Jane
NextGen Jane turns an ordinary tampon into a liquid-biopsy device, isolating endometrial cells and extracellular RNA from menstrual blood for non-invasive endometriosis and fibroid diagnosis;…
- Country
- United States
Menstrual liquid biopsy
NIH SBIR funded
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| FemTech biotech & women's health | regenerative-personalized | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.